News
Unlocking the Opportunity in Axial Spondyloarthritis - Treating the Visible and the Invisible
17 December 2020
Looking at the autoimmune disease that affects the axial skeleton and the treatments involved in it
Read more
Keep Looking: Beyond Market Research Methodologies
26 October 2020
The world is changing rapidly in healthcare and the simple extrapolation of existing trends is unlikely to provide insight that drives differentiation. Instead we must look deeper taking a broad view of markets to better understand current and future forces that will impact brands.
Supporting Young Minds
09 October 2020
This World Mental Health Day, Vox.Bio have once again supported Young Minds with their Hello Yellow campaign
Read more
Has COVID-19 Indefinitely Disrupted the Pharma Sales Model?
17 August 2020
In March, COVID-19 halted face to face Pharma sales teams, as healthcare systems start to open up, we ask has the model been indefinitely changed?
Read more
The Gene Therapy Revolution Has Arrived. But What’s Next?
04 August 2020
Three gene therapies have been successfully been approved over the last 2 years, revolutionising the treatment of rare, detrimental diseases. The landscape is now blossoming with hundreds of gene therapies in clinical development.
Read more
Is the US Finally Ready for the Biosimilar Boom?
20 July 2020
The emergence of biosimilars has provided promise of increased cost-savings and increased patient accessibility to biologics. However, this promise has not yet been realised in the US.
Read more
Managing cancer patients during the COVID-19 pandemic
26 June 2020
COVID-19 has impacted all aspects of clinical care globally, including #cancer treatment. A delicate balance needs to be struck between mitigating risk of potential exposure and continuing to ensure access to #cancer treatment and clinical trials.
Read more
Welcome to our new CEO Chris Stevenson
20 May 2020
We are thrilled to announce the appointment of Chris Stevenson as CEO, Chris transitions to this new role from his position on the board as a non-executive director.
Read more
COVID-19 Dissecting the Therapeutic and Vaccine Landscape
28 April 2020
We take a look at where does the most promise lie amidst this rapidly evolving landscape and when will therapeutic studies yield firm evidence of clinical benefit.
Read more
Mindfulness Event
03 April 2020
Maintaining our team's mental well-being is crucial during these challenges times. We recently hosted a well-received mindfulness session to help our team manage the added stress of social-distancing and working from home.
Read more